Heron Therapeutics Shares Outstanding 2006-2019 | HRTX

Heron Therapeutics shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Heron Therapeutics Annual Shares Outstanding
(Millions of Shares)
2018 73
2017 54
2016 38
2015 33
2014 27
2013 16
2012 12
2011 6
2010 2
2009 2
2008 2
2007 1
2006 0
2005 0
Heron Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 80
Q2 2019 80
Q1 2019 78
Q4 2018 73
Q3 2018 78
Q2 2018 72
Q1 2018 65
Q4 2017 54
Q3 2017 54
Q2 2017 54
Q1 2017 51
Q4 2016 38
Q3 2016 39
Q2 2016 37
Q1 2016 36
Q4 2015 33
Q3 2015 36
Q2 2015 31
Q1 2015 29
Q4 2014 27
Q3 2014 29
Q2 2014 24
Q1 2014 24
Q4 2013 16
Q3 2013 15
Q2 2013 15
Q1 2013 15
Q4 2012 12
Q3 2012 14
Q2 2012 10
Q1 2012 10
Q4 2011 6
Q3 2011 10
Q2 2011 2
Q1 2011 2
Q4 2010 2
Q3 2010 2
Q2 2010 2
Q1 2010 2
Q4 2009 2
Q3 2009 2
Q2 2009 2
Q1 2009 2
Q4 2008 2
Q3 2008 2
Q2 2008 2
Q1 2008 2
Q4 2007 1
Q3 2007 2
Q2 2007 0
Q1 2007 0
Q4 2006 0
Q3 2006 0
Q2 2006 0
Q1 2006 0
Q4 2005 0
Q3 2005 0
Q2 2005 0
Q1 2005 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.318B $0.077B
Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.153B 9.98
Zoetis (ZTS) United States $57.975B 34.68
Astellas Pharma (ALPMY) Japan $32.884B 16.42
Eisai (ESALY) Japan $21.873B 42.18
Grifols, S.A (GRFS) Spain $15.793B 20.69
UCB SA (UCBJF) Belgium $15.697B 0.00
Merck (MKGAF) Germany $14.809B 20.21
Neurocrine Biosciences (NBIX) United States $10.757B 507.87
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $9.088B 18.41
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.455B 10.80
IPSEN SA ADR (IPSEY) France $7.796B 0.00
Catalent (CTLT) United States $7.615B 30.98
Arrowhead Pharmaceuticals (ARWR) United States $6.438B 97.49
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.263B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.698B 16.89
FibroGen (FGEN) United States $4.135B 121.51
United Therapeutics (UTHR) United States $4.020B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.774B 13.79
Nektar Therapeutics (NKTR) United States $3.598B 0.00
Sage Therapeutics (SAGE) United States $3.340B 0.00
Evotec AG (EVTCY) Germany $3.326B 54.42
PTC Therapeutics (PTCT) United States $3.032B 0.00
Xencor (XNCR) United States $2.329B 70.79
Portola Pharmaceuticals (PTLA) United States $2.273B 0.00
Zogenix (ZGNX) United States $2.074B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.957B 62.40
Pacira Pharmaceuticals (PCRX) United States $1.914B 56.63
Tilray (TLRY) Canada $1.829B 0.00
ChemoCentryx (CCXI) United States $1.816B 0.00
USANA Health Sciences (USNA) United States $1.652B 17.63
Corcept Therapeutics (CORT) United States $1.520B 18.47
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.456B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.264B 28.86
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.197B 0.00
ArQule (ARQL) United States $1.167B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.112B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.101B 7.51
Endo (ENDP) Ireland $1.098B 2.02
Karyopharm Therapeutics (KPTI) United States $1.023B 0.00
Radius Health (RDUS) United States $1.012B 0.00
Aerie Pharmaceuticals (AERI) United States $0.920B 0.00
Flexion Therapeutics (FLXN) United States $0.746B 0.00
Collegium Pharmaceutical (COLL) United States $0.706B 0.00
Akebia Therapeutics (AKBA) United States $0.703B 0.00
TherapeuticsMD (TXMD) United States $0.659B 0.00
Translate Bio (TBIO) United States $0.600B 0.00
ImmunoGen (IMGN) United States $0.579B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.493B 0.00
Organogenesis Holdings (ORGO) United States $0.484B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.481B 58.38
Harpoon Therapeutics (HARP) United States $0.466B 0.00
Molecular Templates (MTEM) United States $0.452B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.440B 0.00
Ardelyx (ARDX) United States $0.430B 0.00
Dermira (DERM) United States $0.430B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.406B 17.52
BioCryst Pharmaceuticals (BCRX) United States $0.396B 0.00
Indivior (INVVY) United States $0.385B 1.39
DURECT (DRRX) United States $0.377B 0.00
Recro Pharma (REPH) United States $0.375B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.364B 0.00
Siga Technologies (SIGA) United States $0.359B 8.20
Innate Pharma SA (IPHYF) France $0.358B 0.00
Lannett Co Inc (LCI) United States $0.355B 4.13
OptiNose (OPTN) United States $0.352B 0.00
Concordia (CXRXF) Canada $0.333B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.332B 0.00
Rafael Holdings (RFL) United States $0.318B 0.00
GlycoMimetics (GLYC) United States $0.260B 0.00
Jounce Therapeutics (JNCE) United States $0.259B 3.46
KalVista Pharmaceuticals (KALV) United States $0.256B 0.00
Calithera Biosciences (CALA) United States $0.252B 0.00
Xeris Pharmaceuticals (XERS) United States $0.236B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.236B 0.00
Ocular Therapeutix (OCUL) United States $0.210B 0.00
Aquestive Therapeutics (AQST) United States $0.201B 0.00
Nature's Sunshine Products (NATR) United States $0.189B 32.57
Foamix Pharmaceuticals (FOMX) Israel $0.187B 0.00
Concert Pharmaceuticals (CNCE) United States $0.175B 0.00
Taiwan Liposome (TLC) Taiwan $0.161B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.149B 0.00
MEI Pharma (MEIP) United States $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.144B 0.00
IMV INC (IMV) Canada $0.143B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.141B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.137B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Champions Oncology (CSBR) United States $0.091B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.089B 0.00
CV Sciences (CVSI) United States $0.085B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 23.45
MediWound (MDWD) Israel $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
PolarityTE (PTE) United States $0.076B 0.00
Neos Therapeutics (NEOS) United States $0.073B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
Capnia (SLNO) United States $0.070B 0.00
Aclaris Therapeutics (ACRS) United States $0.069B 0.00
Cardiome Pharma (CORV) Canada $0.066B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.058B 0.00
Novan (NOVN) United States $0.057B 0.00
Nivalis Therapeutics (ALPN) United States $0.057B 0.00
Genocea Biosciences (GNCA) United States $0.056B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Natural Alternatives (NAII) United States $0.055B 13.73
CTI BioPharma (CTIC) United States $0.054B 0.00
Medicure (MCUJF) Canada $0.054B 0.00
IntelGenx Technologies (IGXT) Canada $0.051B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.049B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Mast Therapeutics (SVRA) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.041B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.037B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
PharmAthene (ALT) United States $0.029B 0.00
Biomerica (BMRA) United States $0.028B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.024B 0.00
Melinta Therapeutics (MLNT) United States $0.024B 0.00
Bio-Path Holdings (BPTH) United States $0.023B 0.00
Shineco (TYHT) China $0.021B 0.00
China SXT Pharmaceuticals (SXTC) China $0.020B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Vical (BBI) United States $0.016B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Forward Pharma (FWP) Denmark $0.000B 0.00